About
Contact & Profiles
A5004206340
Research Areas
- vaccines and immunoinformatics approaches
- Viral gastroenteritis research and epidemiology
- SARS-CoV-2 and COVID-19 Research
Hospital Regional Universitario de Málaga
2024
(1) Background: The global coronavirus disease 2019 vaccination adapts to protect populations from emerging variants. This communication presents interim findings the new Omicron XBB.1.16-adapted PHH-1V81 protein-based vaccine compared an XBB.1.5-adapted mRNA against various acute respiratory syndrome 2 (SARS-CoV-2) strains. (2) Methods: In a Phase IIb/III pivotal trial, adults previously vaccinated with primary scheme and at least one booster dose of EU-approved randomly received either or...
10.3390/vaccines12080840
article
EN
cc-by
Vaccines
2024-07-25
Coming Soon ...